DOI: 10.1128/AAC.02397-17
Article Information
PubMed
Published By
History
- Received November 21, 2017
- Returned for modification December 6, 2017
- Accepted December 15, 2017
- Published online February 23, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (December 20, 2017).
- You are viewing the most recent version of this article.
Author Information
- Address correspondence to Helio S. Sader, helio-sader{at}jmilabs.com.
Citation Sader HS, Mendes RE, Duncan LR, Pfaller MA, Flamm RK. 2018. Antimicrobial activity of dalbavancin against Staphylococcus aureus with decreased susceptibility to glycopeptides, daptomycin, and/or linezolid from U.S. medical centers. Antimicrob Agents Chemother 62:e02397-17. https://doi.org/10.1128/AAC.02397-17.
